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Summary
Chronic cerebrospinal venous insufficiency (CCSVI)
is a term used to describe impaired venous drainage
from the central nervous system (CNS) caused by ab-
normalities in anatomy and flow affecting the ex-
tracranial veins. Recently, it has been proposed that
CCSVI may contribute to the pathogenesis of multiple
sclerosis (MS). It is hypothesized that venous obstruc-
tion results in abnormal flow that promotes inflamma-
tion at the blood-brain barrier and that this triggers a
process marked by a disturbance of homeostasis
within the CNS that leads to demyelination and neu-
rodegeneration. The venous abnormalities of CCSVI
are often diagnosed by ultrasound or magnetic reso-
nance venography, however the prevalence of CCSVI
detailed in groups of MS patients and patients without
MS varies widely in published reports. Increased stan-
dardization of diagnostic studies to evaluate both
anatomical and physiological findings associated with
CCSVI is needed. The purpose of this article is to pro-
vide a background to understand the development of
the theory of CCSVI and to frame the relevant issues
regarding its diagnosis and relationship to the patho-
genesis of MS.
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Historical perspective
Multiple sclerosis (MS) is a chronic demyelinating and
degenerative disease that affects the central nervous
system (CNS). It is estimated that it currently affects
400,000 individuals in the U.S. and with 12,000 new
cases annually, more people are being diagnosed now
than in the past. It is a disease with disseminated brain
and spinal cord lesions, a wide variety of different neu-
rological symptoms, and typically a ﬂuctuating clinical
course. The symptoms of this multicentric process are
manifest during acute relapses of the disease or after a
period of disease progression. While the clinical course
of MS is highly variable, in most cases it leads to severe
and irreversible disability (1-3). 
Recognized and described over 150 years ago, the ex-
act cause of MS remains unknown. Credit for the ﬁrst
complete clinical and pathological account of MS is at-
tributable to Charcot, the renowned French neurologist
(4).He ﬁrst became familiar with the progress of the dis-
ease through daily observation of his housemaid, who
had nystagmus, intention tremor, and scanning speech.
He used freehand cut brain sections and primitive meth-
ods of staining in a number of cadaver brains to identify
the salient histopathological features of the disease and
emphasized the loss of myelin sheaths, the preservation
of nerve ﬁbers, and the proliferation of glia.
It is now generally held that an autoimmune mechanism
is responsible for the disease, but how the initial reac-
tion is triggered and the process sustained remains un-
clear. Multiple factors (genetic, infectious, environmen-
tal, nutritional, etc.) have been implicated in the etiology
of MS and an interaction between various factors could
potentially explain the heterogeneity observed in studies
of both the pathological character of MS lesions and the
nature of disease manifestations. To date, no single fac-
tor is known to be causal (2,3).
Chronic cerebrospinal venous insufﬁciency (CCSVI) is a
recently described condition that may possibly contribute
to the symptoms often experienced by patients with MS
(5,6). The idea that the vascular system is somehow re-
lated to the pathological abnormalities of MS was pro-
posed shortly after the characteristic lesions were de-
scribed. Of the early investigators of the disease, Char-
cot was the ﬁrst to describe the obstruction of blood ves-
sels within MS lesions (4). Indeed, the vascular hypothe-
sis was widely advocated as the most plausible explana-
tion for the pathogenesis of MS during the late 1800s. 
Observations by Rindﬂeisch and others detailed blood
vessels within the middle of each white matter lesion
(7,8). In 1863, Rindﬂeisch wrote, “if one looks carefully
at freshly altered pats of the white matter, one perceives
already with the naked eye a red point or line in the mid-
dle of each individual focus, the lumen of a small vessel
engorged with blood. All this leads us to search for the
primary cause of the disease in an alteration of individ-
ual vessels and their ramiﬁcations.” 
Then, during the mid-20th century, the recognition that
these central vascular channels were abnormal cere-
bral veins fueled enthusiasm for the concept of a vascu-
lar etiology. During this period, researchers including
Putnam, Marburg, Dow, Fog, Adams, Engell and others
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(9-23) contributed to advancing an understanding of the
role of abnormal venous involvement in MS, but over the
last 50 years the vascular hypothesis has been eclipsed
by emerging evidence that strongly supports a primary
autoimmune basis for the disease.
Chronic cerebrospinal venous insufﬁcency
Recently, Zamboni and colleagues revitalized interest in
the importance of cerebrospinal venous drainage as a
factor that inﬂuences the pathogenesis of MS (6,24,25).
They described ultrasonographic and venographic evi-
dence of extracranial venous obstruction involving the
internal jugular, vertebral, deep cerebral and azygos
veins in a remarkably high percentage of patients diag-
nosed with MS. Comparatively, similar ﬁndings were not
diagnosed in healthy control subjects and patients with
other neurological diseases. They proposed that CCSVI
interferes with venous drainage from the CNS, and that
this contributes to the development and progression of
MS. Moreover, when the stenotic lesions in the internal
jugular and azygo veins were treated endovascularly
with balloon angioplasty, they observed in many patients
a rapid and often dramatic improvement in a variety of
symptoms (25). This approach was in fact not dissimilar
to that taken in treating paraplegic and quadriplegic pa-
tients in the 1970s by Aboulker et al. (26,27). During this
time, Aboulker and colleagues treated hundreds of pa-
tients and pioneered the pathogenetic concept of ve-
nous hypertension as primarily responsible for the neu-
rological abnormalities. They documented lesions not
only in the jugular and azygos veins, but also in the bra-
chiocephalic, superior vena cava and iliac veins. 
Zamboni and co-authors detailed the non-invasive de-
tection of CCSVI by combined transcranial and extracra-
nial color Doppler ultrasonography. This speciﬁc exami-
nation included the evaluation of ﬁve parameters to as-
sess venous blood ﬂow and anatomy (6,24). The study
was considered diagnostic of CCSVI if a patient had an
abnormality in two or more of the ﬁve criteria studied.
The diagnosis of CCSVI by these investigators was
highly associated with all forms of MS, irrespective of
the relapsing-remitting or progressive nature of the dis-
ease in the group of patients tested. They hypothesized
that the venous abnormalities identiﬁed are responsible
for derangements in the normal patterns of blood ﬂow
draining from the CNS and consequently cause inﬂam-
matory reactions at the blood-brain barrier that lead to
altered permeability and a cascade of untoward
changes including iron deposition, degeneration of neu-
rons and characteristic forms of brain injury typical of
MS (5,28).
The publication of these ﬁndings unleashed an emotion-
ally intense controversy that currently still foments with
boiling points of view. From highly critical reactions that
decry the concept of CCSVI as a hoax that provides
false hope to vulnerable and desperate individuals to
supportive testimonials from treated patients, the debate
surrounding the existence, association and relevance of
CCSVI to MS is reﬂected in the contributions to the med-
ical literature. Although the vast majority of the articles
on the topic consist of commentaries, opinions, interpre-
tations and diatribes rather than reports of clinical evi-
dence for or against CCSVI, the essence of the recent-
ly published independent clinical studies designed to
evaluate various aspects of the CCSVI hypothesis do,
by and large, reﬂect the opposing public contentions in
the dispute by presenting conﬂicting results that either
pointedly question or support the existence of CCSVI
(29-33). At present, our level of understanding is simply
insufﬁcient to settle the argument (34,35).
Many of the reports in the literature have focused on
corroborating the ultrasound results initially published by
Zamboni. Some authors presented ﬁndings that did not
conﬁrm an increased frequency of venous abnormalities
in MS patients relative to healthy control subjects or pa-
tients with other neurological diseases, while others
found positive CCSVI ultrasound criteria more common-
ly in MS patients compared to controls (36-38). Other
studies have evaluated MR venography, MR determina-
tions of jugular venous ﬂow, brain perfusion, iron content
and MR evaluations of intracerebral total venous volume
in patients with and without diagnosed CCSVI, as well
as traditional catheter venography, ultrasonography, and
functional MR studies before and after endovascular
treatment of patients with CCSVI (39-44). Despite these
independent single center efforts, it will require another
level of controlled, collaborative multimodal research
with agreement on clear deﬁnitions of standards for
CCSVI testing, interpretation, and diagnosis before the
confusion can be resolved (29,34).
Pathogenesis of MS in relation to venous
alterations
In recognition of our current inability to fully understand
the role, if any, of CCSVI and its relevance to the patho-
genesis of MS (34,35), other neurological diseases or
healthy subjects, it may be interesting to review some of
the historical pre-CCSVI evidence that supports the
functional inﬂuence of venous involvement and its pos-
sible importance to the pathogenesis of MS. In this re-
gard, these contributions provide the foundational un-
derpinning for the current CCSVI theory. Perhaps, one
of the more interesting areas of observational research
involves the similar appearances of veins that are sub-
jected to chronic obstruction in a variety of venous terri-
tories throughout the body (Fig. 1). Histopathological ex-
amination of leg veins from patients with chronic lower
extremity deep venous thrombosis, hepatic veins in pa-
tients with Budd-Chiari, and retinal veins in patients with
chronic forms of optic neuritis show the same response
that has been observed in cerebral veins located within
the brain lesions in MS patients (45,46). 
Regardless of the location of the involved vascular bed,
veins that are exposed to chronic downstream obstruc-
tion respond to the associated sustained increase in
pressure (even though it may be only modestly elevated
over normal at rest) and ﬂow disturbances in a charac-
teristic manner by forming a “ﬁbrin cuff” that encircles a
typically dilated vessel lumen as a proliferative thickened
wall consisting of concentric lamellae of hyaline material
that replaces the normal lacy perivenous connective tis-
sue (Fig. 2) (5,28). This interesting adaptive structural
reaction to venous insufﬁciency is similar throughout the
body, irrespective of the etiology or location of the ve-
nous obstruction. In relation to MS, the effects of this ve-
nous involvement and its relationship to the pathogene-
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Figure 1 - Venous obstruction due to extrinsic compression of the left common iliac vein.
(a) Left iliac venogram with compression of left common iliac vein caused by overlying right common iliac artery as it crosses ante-
rior to the vein. Posteriorly, the spine prevents displacement of the vein. This is typical of the May-Thurner syndrome with left com-
mon iliac vein obstruction. The narrowing is seen as a diagonal effacement of the contrast column coursing across the vein from up-
per left to lower right, corresponding to an extrinsic compression from the right common iliac artery. (b) Similar venographic appea-
rance of the left common iliac vein in an older individual with asymmetric left leg swelling. Note the calciﬁed aorta and right iliac ar-
tery that allow appreciation of the relationship between the crossing artery and the obstructed left common iliac vein. Also evident are
numerous transpelvic venous collaterals that provide ﬂow around the obstruction. (c) Intravascular ultrasound image with catheter lo-
cated in the left iliac vein. The vein is markedly narrowed by the overlying iliac artery that is located anteriorly at 12 o’clock (arrow).
a b c
Figure 2 - Budd-Chiari syndrome with chronic venous obstruction. 
(a) Inferior vena cavogram with intrahepatic stenosis (asterisk) associated with multiple collateral channels (arrows) in 30-year-old
woman with history of oral contraceptive use and symptoms of abdominal pain and swelling. (b) Photomicrograph of a transjugular li-
ver biopsy specimen in this patient with ﬁndings typical of Budd-Chiari syndrome. Thickened hepatic vein wall (arrow) is noted with
proliferative changes comprising a hyalinized ﬁbrin cuff around the chronically obstructed vein. Also evident is perivenular congestion
with clustering of red blood cells. (original magniﬁcation, x40; hematoxylin-eosin stain)
a b
sis of the CNS involvement have been explored for
decades as an unexplained curiosity in an unexpected
academic venue—the ophthalmology literature.
Optic neuritis is recognized as one of the most common
ﬁrst manifestations of MS. It is estimated that 66% of MS
patients will have at least one episode of optic neuritis
(47,48). The symptoms of optic neuritis or retrobulbar
neuritis usually include acute blurring or loss of vision
that typically involves one eye. Not everyone who expe-
riences optic neuritis develops MS. Over a 10-year peri-
od after an episode of optic neuritis, it is estimated that
about 40% of individuals will be diagnosed with MS (49).
While not every case of optic neuritis is associated with
MS, C. Wilbur Rucker, an ophthalmologist at the Mayo
Clinic, described, over 60 years ago, in 1944, a “pecu-
liar white sheathing of some of the retinal veins” ob-
served on fundoscopic examination of MS patients
(47,48). This retinal vein sheathing “appears as a thick-
ening of the walls of the veins, especially in their periph-
eral branches, and there occasionally may be constric-
tion in caliber of the lumen.” Further studies by Rucker
and others revealed that this phenomenon is detected in
about 10% to 23% of patients with MS; furthermore,
when it is documented, the vast majority of the affected
patients (85% to 90%) have or eventually progress to a
diagnosis of MS (50,51).
In 1976, Younge performed ﬂuorescein angiographic ob-
servations in a group of patients with retinal vein sheath-
ing and MS (52). He reported “smudge-like” ﬂuorescein
staining of the vein wall 15 minutes after the dye was ad-
ministered and leakage spreading into the region of
sheathing at 30 minutes. He believed the breakdown in
the blood-retinal barrier to be a form of perivasculitis that
represented a contributing factor in the sheathing
process. Interestingly, Broman, working in Lund in 1947,
described similar staining with a supravital dye within
the white matter plaques in two cases of MS (53). The
disturbed cerebral vascular venous permeability he ob-
served most notably occurred within the lesions at ves-
sel branch points. Hamrick and King recounted in the
ophthalmology literature that one of the early theories
regarding the retinal venous phenomenon, regardless of
its cause, was that it “might be the underlying lesion pro-
ducing the clinical disease of multiple sclerosis,” and
“thus it has been postulated that a mild form of localized
phlebitis may be responsible for the demyelinating
process” (54).
Subsequently, Lightman, et al., in 1984 published a
“systematic study” of the frequency of retinal vascular
abnormalities in 50 patients presenting with acute optic
neuritis (55). None of the patients had a diagnosis of MS
at the time of initial examination and enrollment in the
study. Abnormalities were detected in 14 of the patients
with optic neuritis, including 10 cases of ﬂuorescein
leakage and 6 cases of perivenous sheathing. After a
mean follow up of 3.5 years, MS had developed in 8 of
the 14 patients with vascular abnormalities (57%). This
represented a statistically signiﬁcant difference (p<0.02)
in the occurrence of MS compared to the patients with-
out vascular lesions diagnosed. He concluded that, “The
presence of perivenular abnormalities in a region free of
myelin and oligodendrocytes provides evidence that the
vascular changes in MS can occur independently of
contiguous demyelination, and may be the primary
event in the formation of new lesions”(55). 
Allen observed that the perivascular cufﬁng in the retina
in optic neuritis and MS occurs in a region which is free
of myelin and oligodendrocytes which cannot therefore
be necessary for the initiation of the cellular inﬁltration
and vascular changes (56). Lightman then strongly ar-
gued against the view that “the vascular changes in MS
are secondary to myelin breakdown produced in some
other way” and focused attention on the possibility that
“the primary events leading to demyelination occur at
the vascular endothelium” (55). In a 1987 publication,
Shaw stressed the “importance of retinal periphlebitis in
MS in increasing our understanding of the pathogenesis
of demyelinating plaques in the central nervous system”
and proceeded to be the ﬁrst to describe the histopathol-
ogy of the retinal lesion in detail (57).
In his discussion, Shaw (57) noted that Adams (20) had
previously suggested that perivenular inﬂammatory cell
cufﬁng in the CNS may be the ﬁrst event in plaque for-
mation. Fog (17) and others (58,59) had also argued
that the occurrence of periphlebitis retinae favors the hy-
pothesis that vascular changes are the primary factor in
the genesis of MS plaques. Shaw reported that if the
“ﬁndings of the present study are combined with the pre-
viously reported histological studies (of cerebral MS le-
sions), a picture emerges of the active and chronic
stages of periphlebitis retinae associated with multiple
sclerosis. In the active phase the vascular changes re-
semble those around vessels in the acute phase of CNS
plaque formation. In many chronic CNS plaques, blood
vessels have thick collagenous walls. These appear-
ances are similar to the ﬁndings we describe in the case
of chronic periphlebitis retinae. Such histological similar-
ity between the vascular changes in CNS plaques and
retinal periphlebitic lesions suggests that they may have
a common pathogenesis. Periphlebitis may therefore be
an initial event in plaque formation, as has been sug-
gested by several other authors. If this is the case, pe-
riphlebitis retinae may represent the basic lesion of MS
in a clinically visible site” (57).
So, if a perivenulitis involving segments of the cere-
brospinal blood-brain barrier is a component of the
pathogenetic process in MS and myelin and/or myelin-
related proteins are not inciting factors requisite for the
process, what is causing the reaction? The truth is, it is
still not known what triggers the initial events in MS.
Most scientists believe that a combination of several fac-
tors may be involved. In this context, CCSVI may repre-
sent one of these contributing factors (35). As such, it is
of interest to review some of the existing evidence that
supports the hypothetical rationale for CCSVI involve-
ment in MS. As mentioned in a recent review, perhaps it
is time to consider the concept of “vascular immunology”
as a focus in understanding the immunological effects of
disrupting the vascular system (35).
Overview of diagnostic issues in relation to CCSVI 
As previously discussed, the venous stenoses de-
scribed in CCSVI involve predominantly the internal
jugular and azygos veins, but in theory because it is the
existence of venous obstruction that is important, rather
than its precise location, the narrowing of other veins
draining the cerebrospinal axis may play a role. These
may include intracranial channels such as major intrac-
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erebral veins, ophthalmic veins, petrosal sinuses and
dural sinuses, as well as extracranial vessels including
the vertebral veins, left brachiocephalic vein or normally
existing collateral neck veins (25). In terms of venous in-
sufﬁciency affecting the more commonly involved inter-
nal jugular and azygos veins, the presence of multiple
lesions affecting one or more veins is frequently ob-
served in CCSVI. Present experience with endovascular
treatment of CCSVI consistently details a mean number
of lesions detected in a range of 1.6 to 1.8 stenoses per
patient evaluated (25,60-62).
The exact location of the internal jugular lesions ob-
served is variable. Similarly, the cause of venous nar-
rowing at any level may be different, with detection of
both intrinsic vein abnormalities and extrinsic compres-
sion which may be a dynamic or ﬁxed obstruction. In this
regard, however, some more commonly identiﬁed pat-
terns of venous obstruction have emerged. By far the
most frequently identiﬁed site of venous abnormalities is
at the region of the jugular valve just cephalad to the in-
ternal jugular conﬂuence with the brachiocephalic veins
on either side, but narrowing within the high and mid-
cervical segments of the internal jugular vein have also
been recognized (40,41,43,60-63).
The high internal jugular stenoses are commonly asso-
ciated with displacement and compression of the vein as
it courses over the anterior aspect of the lateral mass of
the C1 vertebral body (Fig. 3). As the internal jugular
vein (sigmoid sinus) exits the skull and becomes the
jugular bulb, it is directed anteriorly to sweep over the
lateral arch of the ﬁrst cervical vertebra. The angle the
vessel must assume as it passes from the jugular fora-
men to its position in front of the bone is variable de-
pending on an individual’s anatomical structure and any
distortion of the vein associated with its position at this
level may be accentuated or reduced by a variety of ori-
entations of the head and neck. Supine or prone pos-
ture, ﬂexion or extension of the neck, ipsilateral or con-
tralateral rotation of the head, as well as maneuvers that
combine these positions may all inﬂuence the degree of
any stretching of the internal jugular and resultant ve-
nous obstruction.
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Figure 3 - Narrowing of the upper segment of the internal jugular vein. 
(a) Sagittal image from CT venography of the neck with marked displacement and narrowing of the internal jugular vein by the bony
lateral mass of the C1 vertebral body located posterior to the vein. (b) Lateral projection of conventional catheter-based contrast ve-
nography with extrinsic stenosis at the level of the C1 vertebral body. Multiple posterior collateral venous channels (vertebral, epidu-
ral, etc.) are evident. (c) MR venography of the head and neck presented in the sagittal view provides an example of a high internal
jugular vein narrowing with associated collateral network of veins. (d) Axial MR venographic image with ﬂattening of the upper seg-
ments of the internal jugular veins bilaterally, worse on the left side than the right (arrows). This is at the level of the C1 vertebral body
where the transverse processes of C1 are directly posterior to the internal jugular veins. Posterior collateral channels, more promi-
nent on the left side, are noted. (e) Intravascular ultrasound image of the internal jugular vein at the C1 level depicts asymmetric nar-





The potential for consequences related to transient ex-
trinsic internal jugular venous obstruction at this level
have been highlighted in the neurosurgery literature
(64). In an effort to investigate the cause of multiple re-
ports of cerebellar hemorrhage secondary to venous in-
farction, not arterial bleeding, after supratentorial cran-
iotomy or, less commonly, cervical spine surgery,
Seoane and Rhoton performed microsurgical anatomi-
cal dissection of the internal jugular vein in the upper
cervical segment in 36 adult cadaveric specimens. In
every specimen examined, the posterior wall of the in-
ternal jugular vein rested against the transverse process
of the atlas as the vein descended immediately below
the jugular foramen. In 14 of the 36 specimens, the
transverse process indented the posterior wall of the
vein, causing the vein to be “slightly or moderately an-
gulated” as it coursed over bone. In three specimens
(8%), the vein was “severely kinked” and distorted (64).
They concluded that obstruction of ﬂow in the internal
jugular vein at the site where the vein descends across
the transverse process of C1 is the most likely cause of
the venous hypertension that resulted in the cerebellar
hemorrhage reported in numerous cases after supraten-
torial craniotomy. After examining the associated biome-
chanics of the region, they conﬁrmed that rotating the
head to the side opposite a supratentorial craniotomy
and extending the neck, common practices in unilateral
supratentorial craniotomy, further exaggerates the angu-
lation and aggravates obstruction of the internal jugular
vein at the C1 transverse process on the side ipsilateral
to the craniotomy. The extent to which the obstruction of
the internal jugular vein at C1 raises transmural intra-
venous pressure depends on the degree of communica-
tion between the transverse sinuses at the torcula and
on the ability of the contralateral sinus to accommodate
the increased ﬂow caused by outﬂow obstruction of the
opposite sinus. 
This obstruction probably has no critical consequence in
the presence of a torcula that communicates openly with
transverse sinuses of equal size. However, if the trans-
verse sinuses are different in size and do not communi-
cate at the torcula, the venous pressure proximal to the
obstruction may have a critical effect resulting in venous
infarction (65-67). Browning reported in 100 cadaveric
dissections that there was a common pool with free
communication at the torcula in only 36% of cases, that
the right and left transverse sinuses balanced in size
with neither sinus being dominant in only 20% of cases,
and that the right was dominant in 51% and the left was
dominant in 29% (65). The more frequent dominance of
the right transverse sinus correlated well with the fact
that the majority of the literature cases of venous infarc-
tion and cerebellar hemorrhage followed right-sided
supratentorial craniotomies.
In this regard, a previous imaging study of MS patients
and healthy subjects observed a high incidence of ve-
nous stenosis at the level of the lateral mass of the C1
vertebral body in both groups (68). The presence of a
mild indentation of the posterior wall of the internal jugu-
lar vein may be a physiologically irrelevant observation
at this level, much like the similar narrowing of the left
common iliac vein by an overlying right common iliac ar-
tery, frequently evident on CT imaging of the pelvis in
patients presenting with complaints other than left leg
symptoms. Indeed, there appears to be a spectrum of
luminal compromise ranging in severity from mild exter-
nal venous compression to severe narrowing by adja-
cent structures in a variety of anatomical locations. The
exact nature, cause and potential consequence may be
highly variable. Typically, it is only when these stenoses
are critically severe that related symptoms may occur,
such as left leg swelling, pain and occasionally venous
thrombosis as noted in the May-Thurner syndrome. 
It is interesting to note that in a 2005 published report of
188 consecutive patients undergoing either central ve-
nous access (40%) or interventional procedures (60%)
such as transjugular liver biopsy via the internal jugular
vein under ultrasound guidance, there were only two
complications (69). One patient with renal failure re-
quired evacuation of a hematoma one week following
placement of a tunneled dialysis catheter. The other
complication occurred in the only patient in the study
with a diagnosis of MS. He underwent tunneled insertion
of a large caliber hemophresis catheter into the right in-
ternal jugular vein. Immediately after the procedure, the
patient complained of left foot numbness never before
experienced, as well as numbness of the upper chest.
In the mid-cervical segment, the internal jugular vein has
a variable anatomical relationship with the carotid artery
(69). Speciﬁcally, the position of the internal jugular vein
relative to the distal common carotid artery and its bifur-
cation may inﬂuence the caliber of the more compliant
vein causing a dynamic extrinsic compression of the ve-
nous lumen. A number of cross-sectional imaging and
ultrasonographic studies have examined the anatomical
relationship between the locations of the carotid artery
and the internal jugular vein in the neck. Typically, at the
mid-cervical level the internal jugular vein resides an-
terolateral to the carotid artery. This position of the vein
between directly anterior and directly lateral to the
carotid artery occurs in approximately 85% of the cases
studied. In about 5% to 6% of cases, the internal jugular
vein is positioned directly anterior to the carotid artery in
the mid-neck (61). In either of these situations, where
the internal jugular vein is located anterolateral or ante-
rior to the carotid artery, conspicuous distortion of the
contour of the vein by the adjacent artery is uncommon. 
In the 9% to 10% of cases in which the internal jugular
vein is located directly lateral to the carotid artery, the lu-
minal shape of the vein on cross-sectional imaging and
its form on traditional catheter venography may be dis-
ﬁgured with an appearance typical of extrinsic compres-
sion – in this case, caused by the impinging, higher
pressure, thick-walled artery. This is most commonly ob-
served in cases with an ectatic, sweeping carotid bifur-
cation that smears across the neighboring internal jugu-
lar vein (Fig. 4). The venographic appearance of this ef-
fect is typical. The frontal venographic projection shows
a medial parabolic impression on the lumen of the jugu-
lar vein and the lateral view has a telltale diagonal,
slash-like effacement of the luminal column of contrast.
The extent of luminal narrowing and prominence of col-
lateral vessels associated with the extrinsic obstruction
is variable and any related hemodynamic effects may be
transient as clearly demonstrated by the changing veno-
graphic appearance that is observed with dynamic pa-
tient maneuvers, including neck rotation. It is possible
that changing respiratory phases and the status of in-
travascular volume may also impact on the degree of
any abnormality. 
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In addition, below the carotid bifurcation at approxi-
mately the level of the C6 and C7 vertebral bodies and
the thyroid gland, there may be transient dynamic com-
pression of the internal jugular vein subjacent to the
sternocleidomastoid muscle group. This may be appar-
ent venographically as an extrinsic obstruction of the
internal jugular, however, this narrowing may dramati-
cally change with complete resolution following rotation
of the head to the side contralateral to the vein in ques-
tion (68). 
By far and away, the segment of the jugular vein that
has received the most scrutiny in CCSVI is the lower re-
gion that encompasses the jugular valve and immedi-
ately proximal regions in the inferior part of the vein (Fig.
5, over). Typically, there is one bicuspid valve in an in-
ternal jugular vein located just above its junction with the
subclavian and brachiocephalic veins. There are reports
in the literature of a wide spectrum of abnormalities as-
sociated with the valve, its annular wall attachment, and
their effect on the diagnosis of CCSVI (6,24,70,71). In-
deed, one of the Zamboni ultrasonographic criteria used
to diagnose CCSVI involves imaging of a proximal (low
or central) obstruction of the jugular in the region of the
valve (24). Increased experience from multiple institu-
tions has provided an opportunity to reﬁne the descrip-
tion of these abnormalities into a few categories. Gener-
ally speaking, a distinction is now made between the ob-
servation of intraluminal abnormalities, such as webs,
membranes, deformed valves, immoveable leaﬂets,
malpositioned leaﬂets, etc., and circumferential, wall-
CCSVI in MS: a historical perspective
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Figure 4 - Extrinsic narrowing of the mid-cervical segment of the internal jugular vein by the common carotid artery and its bifurca-
tion. (a) Axial MR venographic image with crescentic, slit-like narrowing of the left internal jugular vein (arrow) by medial common ca-
rotid artery at its ectatic bifurcation. This appearance is observed only in cases where the vein is positioned directly lateral to the ar-
tery at this level. (b) The obstructive effect of this anatomical relationship is evident on the sagittal MR projection. The carotid artery
at its bifurcation (open arrows) displaces and compresses the medial aspect of the internal jugular vein (arrows). (c) A similar appea-
rance is noted on a lateral image from a conventional catheter-based venogram. Effacement of the venous contrast column with an
obvious extrinsic narrowing (arrows) corresponding to the impression of the carotid artery on the internal jugular vein is apparent in
the mid-cervical segment. (d) Frontal view of left internal jugular venogram with focal asymmetric medial narrowing of vein in its mid-
cervical segment (arrows). The characteristic parabolic impression on the contrast column is caused by the carotid artery if it is im-
mediately medial to the vein. If the carotid is tortuous at this level and directly medial to the vein, it may cause this type of appearan-
ce in the neutral or non-rotated head position. Rotation of the head to the side ipsilateral to the jugular under interrogation may ac-
centuate the degree of obstruction and alternatively, rotation to the opposite side may relieve the narrowing. The dynamic nature of





based constrictions that may be associated with the an-
nulus of the valve (60-62,68,70-72).
The previously listed catalog of intraluminal lesions is by
no means comprehensive and the nomenclature used to
describe the abnormalities is not established. Presently,
the terminology is descriptive, while the etiology (con-
genital or acquired) and relative signiﬁcance of individ-
ual lesions remains unknown. It is consensually estab-
lished that ultrasound imaging is currently the most sen-
sitive non-invasive imaging modality to diagnose any in-
traluminal abnormalities and related ﬂow disturbances.
Catheter-based contrast venography and intravascular
ultrasound have the ability to diagnose abnormalities in
the valve region. Although venography is not capable of
detecting the majority of intraluminal lesions associated
with the valve, it does provide a global view of the vein,
including the caliber of the valve oriﬁce, and the ability
to assess the tempo of contrast drainage through the
jugular in a format that is familiar to interpret. Albeit in-
vasive, catheter-based intravascular ultrasound imaging
can conﬁrm external ultrasound ﬁndings, complement
the venographic assessment, and provide a valuable in-
traprocedural evaluation of intraluminal abnormalities
pre- and post-intervention. 
Recently, there have been reports of gross anatomical
evaluation of tissues associated with the valve in the
lower segment of the internal jugular vein. Diaconu et
al., at the Cleveland Clinic, reported ﬁndings from the
gross and microscopic evaluations of harvested bilater-
al internal jugular, subclavian, brachiocephalic, and azy-
gos veins from 7 deceased MS patients and 6 non-MS
controls (71). Veins were injected with silicone, dissect-
ed en bloc, incised longitudinally to expose the luminal
surface, and ﬁxed. All valves and structural abnormali-
ties were characterized. They detailed marked valvular
and other intraluminal abnormalities with potential he-
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Figure 5 - Internal jugular vein narrowing within the valvular zone of the lower segment. (a) Longitudinal ultrasound image of the lo-
wer left internal jugular vein with septum (arrow) coursing across the transverse extent of the vessel adjacent to the valve. This ab-
normality is one of many that is increasingly recognized in the constellation of intraluminal lesions associated with the valvular region
of the lower jugular. Many of these are associated with venous obstruction, ﬂow abnormalities and a diagnosis of CCSVI. (b) Axial
images from an MR venogram of the neck show prominent valve cusps (arrows) within the right internal jugular vein at the base of
the neck. Conspicuous valvular architecture evident on MR imaging may be associated with a narrowed valvular oriﬁce that is obser-
ved with other imaging modalities. (c) Right internal jugular venogram with ﬁxed narrowing of the valve and obstruction to jugular ve-
nous drainage. Delayed emptying of the jugular vein following contrast injection and the presence of a robust collateral network are
associated with the jugular venous insufﬁciency.
b
a c
modynamic consequences in 5 of 7 MS patients (7 ab-
normalities) and in 1 of 6 controls (1 abnormality). These
abnormalities included circumferential membranous
structures (1 MS and 1 control), longitudinally-oriented
membranous structures (3 MS), single-valve ﬂap replac-
ing the internal jugular vein valve (2 MS), and enlarged
and malpositioned valve leaﬂets (1 MS).
If, indeed, there are more venous abnormalities affect-
ing the jugular and azygos veins in MS patients than in
non-MS subjects, how do any associated changes in the
intra- and extracranial hemodynamics contribute to the
development and progression of MS? The CCSVI con-
ceptual framework argues that a vessel wall, whether ar-
terial or venous, responds dynamically to changes in
ﬂow and pressure (5,46,73,74), such that the pulsatile
shear stress and cyclic strain that the blood-brain barri-
er experiences with changes in venous blood ﬂow can
inﬂuence the degree of local inﬂammation and possibly
the development of thrombosis and tissue injury (73).
Laminar shear stress with normal venous ﬂow promotes
factors that maintain homeostasis and reduce inﬂamma-
tion, while disturbed, turbulent or reversed venous ﬂow
decreases shear stress and promotes a pro-inﬂammato-
ry environment. Recently, Dolic et al. described the he-
modynamic consequence related to extracranial intralu-
minal venous abnormalities; those subjects with a high-
er number of intraluminal abnormalities in the internal
jugular veins presented with a higher number of collater-
al veins in the neck (68). 
In an attempt to elucidate the role of iron, blood ﬂow, le-
sion development and the general association of abnor-
mal vasculature in MS, a number of researchers have
been focusing on the application of advanced MR imag-
ing methods (41,42). There is currently increasing use of
MR imaging internationally that integrates the usual
neurological MR protocol with a CCSVI imaging proto-
col. The former contains sequences that allow for
anatomical and lesion information to be gathered, while
the latter focuses on vascular anatomy, quantitative ﬂow
(for arteries, veins and cerebrospinal ﬂuid) (75) and iron
measurements. The combined protocol provides the
tools necessary to probe the inter-relationship between
ﬂow and lesion development and other aspects of MS
as a neurodegenerative disease. 
The descriptive details of this protocol are provided in
the appendix. Figures 3 through 6 demonstrate the
anatomical information provided by MR angiographic/
venographic (MRAV) methods. The conclusions drawn
from anatomical imaging exclusively have not been con-
vincing, with stenoses appearing in healthy subjects as
well as MS patients. Nevertheless, the anatomical infor-
mation has still proven useful in demonstrating congen-
ital abnormalities, such as truncular venous malforma-
tions including a jugular trunk without any connection to
the upper level jugular, a jugular trunk with a string-like
connection to the upper level jugular, or membranous in-
traluminal material as mentioned above. In an imaging
study of 200 MS patients, the ﬁrst two ﬁndings were di-
agnosed in about 20% of the subjects (42).
In order to complement the anatomical information, it is
important to examine the venous ﬂow (42). It is not un-
common in MS patients to see many vessels in a con-
trast-enhanced scan, but to ﬁnd ﬂow in only one jugular
vein. Figure 7 (over) presents the cross-sectional infor-
mation used for ﬂow quantiﬁcation and ﬁgure 8 (over)
provides four example ﬂow proﬁles seen in normal con-
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Figure 6 - Bifurcation of the right internal jugular vein into two components. 
(a) Coronal 2D time-of-ﬂight (TOF) MR venography (MRV) projection of the neck. The right internal jugular vein shows bifurcation in-
to two components of approximately equal size near the mid-neck level; an anterior oriented component (short arrow) and a poste-
rolateral oriented component (long arrow). The bifurcation of major veins may create obstructions of ﬂow by generating turbulence in
the venous drainage. (b) Sagittal 2D TOF MRV projection of the neck shows that the anterior component has a weak signal (short ar-
row) indicating possible obstruction or abnormal pattern of venous outﬂow compared with the posterolateral component (long arrow)
which shows a strong, solid signal. (c) Coronal 3D contrast-enhanced (CE) MRV, with arterial signals removed to better view venous
structures, shows consistency between modalities in the visualization of patency of the veins of the neck and bifurcation of the right
internal jugular vein (arrows). (d) Sagittal 3D CE MRV of the neck shows the conﬂuence of both the anterior component (short arrow)
and the posterolateral component (long arrow) with the right subclavian vein. A change in signal intensity between the two fenestra-
ted internal jugular vein components is evident.
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Figure 7 - Cross-sectional cut through C7/T1 showing arteries and veins. (a) Magnitude component of phase contrast slice showing
the cross-sectional anatomy of the neck at the C7/T1 level with vessels highlighted due to blood ﬂow through the slice. (b) Phase
component of phase-contrast MRI (PC-MRI) slice showing the direction and speed of ﬂow by signal intensity. The bright signal indi-
cates ﬂow in the caudal-cranial direction, the expected arterial ﬂow as shown in the left common carotid artery (short arrow), and the
dark signal indicates ﬂow in the cranial to caudal direction, the expected venous ﬂow as shown in the right internal jugular vein (long
arrow). (c) Magnitude image with manually outlined contours of the vessels of the neck and regions of low ﬂow, such as muscle, to
correct for any phase offset. (d) Phase image with the manually outlined contours and their enclosed phase intensity which can be
used to quantify blood ﬂow variables. (e) Sagittal T2 weighted image shows the bright signal of the cerebrospinal ﬂuid with clear vi-
sualization of the vertebral column. This image may be utilized to indicate any narrowing of the cervical CSF signals and place the
appropriate positioning of the PC-MRI slice (white localization line) at the C7/T1 neck level. (f) Sagittal 2D time-of-ﬂight MR veno-
graphy projection shows the appropriate positioning of the PC-MRI slice (white localization line) perpendicular to the course of ﬂow
through the internal jugular veins. 
Figure 8 - A series of eight ﬂow proﬁles from a normal control case and three MS cases.
The quantiﬁed integrated ﬂow (a,c,e,g) and volume ﬂow rate vs time (b,d,f,h) plots are shown for each patient taken at the lower neck
level caudal to the conﬂuence of the internal jugular veins with the subclavian vein. (a,b) In a normal control patient, the left internal
jugular vein carries the dominant venous outﬂow and the right internal jugular vein carries the subdominant ﬂow in a ratio of 2.43:1.
The left internal jugular vein shows reﬂux prior to arterial systole as shown in (b) between 350 and 450 ms, however the ﬂow in re-
ﬂux is only a small fraction of the total venous outﬂow volume through the vessel and it occurs for a short period during the cardiac
cycle. (c,d) In the quantiﬁed ﬂow plots of a secondary progressive MS patient the right internal jugular vein carries over 83% of the
total arterial ﬂow and there is not a clear subdominant vein. An observed ﬂow pattern in MS patients is the presence of venous out-
ﬂow dominated by only one vein. Treatment of a patient’s vessel which carries the majority of the venous outﬂow in the presence of
no other clearly developed collateral may be inappropriate as it may unintentionally generate an obstruction of ﬂow in the only func-
tional drainage route. (e,f) The ﬂow plots for a primary-progressive MS patient show the right internal jugular vein is the dominant vein
with the right external jugular vein carrying the subdominant ﬂow. The left internal jugular vein does carry some net venous outﬂow,
however due to a strong reﬂux pattern which is delayed into the arterial systolic phase of the cardiac cycle, it carries only 3% of the
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total arterial ﬂow. This case is differentiated from the minor reﬂux shown previously in the normal control in that the reﬂux component
negates potential venous outﬂow through the internal jugular vein. Abnormal venous outﬂow may be caused by anatomical narrow-
ing such as stenosis, but also may be generated by unusual venous ﬂow patterns as shown in this case. (g,h) Revisiting the relaps-
ing-remitting MS patient shown in ﬁgure 6, this time with the quantiﬁed ﬂow plots, shows another potentially abnormal ﬂow pattern in
which all vessels carry low ﬂow or show reﬂux for a signiﬁcant percentage of the cardiac cycle. In this case, the trend occurs between
275 and 450 ms in all veins and may indicate a transitory lack of appropriate venous drainage. The anterior component of the bifur-
cated right internal jugular vein (RIJV2) shows large reﬂux prior to arterial systole. Note that the pattern here is not delayed as shown
in the previous example and occurs well before the arterial systolic phase. 
trols and in MS patients. However, it is also possible that
one may ﬁnd that there are two normal functioning inter-
nal jugular veins with high ﬂow in MS patients. There are
a good number of MS patients who have only one func-
tioning jugular (and often that is also the major source of
drainage from the head) and it may be inappropriate to
treat these dominant vessels. In the same study of 200
MS patients mentioned above (42), more than 25% had
one dominant jugular (as deﬁned by the criterion of a
dominant to subdominant ﬂow greater than 3:1). Finally,
blood ﬂow from the two dominant draining veins (usual-
ly, but not always, the two jugular veins) appears to have
a lower threshold or cutoff of roughly 8ml/s, with lower
total ﬂow measured in about 25% of the MS patients
evaluated – the majority of whom had venous stenosis
(Fig. 9). On the other hand, none of the 18 normal con-
trol subjects had ﬂow at or below this level measured in
the dominant draining veins. It is possible that a low to-
tal internal jugular vein ﬂow may prove to be a risk fac-
tor for developing MS. 
Linking the autoimmune and vascular components
of MS
Adhesion molecule and cytokine expression, along with
factors that increase oxidative stress within the vein, can
promote leukocyte migration from the bloodstream and
attachment against the vein wall. This sequence of
events is common within all vascular beds and is not ex-
clusive to the blood-brain barrier (5,46,73). Once a
leukocyte adheres to the vein wall, the cell rolls longitu-
dinally along the wall until it sticks to a vulnerable loca-
tion where it inﬁltrates the vein wall, insinuating between
the endothelial junctions until it traverses the perivascu-
lar space. The inﬂammation and injury of the post-capil-
lary venule at the so-called blood-brain barrier allows
migration of other blood constituents, including erythro-
cytes which can lead to abnormal local accumulation of
iron and lymphocytes. Iron in the CNS has an added in-
ﬂammatory effect and both T and B cells within the tis-
sue disrupt homeostasis and cause changes in osmotic
pressure, pH, ion balance, etc., that can disable basic
transport systems which are critical to normal cellular
function (46). These reactions contribute to a neurode-
generative process that once established may result in
sustained destruction with an eventual appearance of
lesions typically described in late-stage MS plaques.
In this regard, is there any evidence to support this con-
cept that MS may be primarily a degenerative disorder
rather than an autoimmune disease? For years, John
Prineas, a globally recognized authority in MS research,
has been interested in exploring the nature of the earli-
est tissue evidence of MS in patients with active lesions
(76). Recently, his research group published the results
of a study of 26 newly-forming active MS lesions in the
brains of 11 patients who died shortly after the acute on-
set of new symptoms (77). Their intent was to catalog
the distribution of inﬂammatory cells within the lesions.
Previously, the group reported that expanding MS le-
sions may exhibit prominent oligodendrocyte loss and
apoptosis – hallmarks of characteristic MS pathological
changes – in the absence of inﬁltrating lymphocytes.
They detailed that parenchymal T and B cells were
largely absent in areas of initial oligodendrocyte loss
and in areas of degenerate and dead myelin inﬁltrated
by myelin phagocytes. In contrast, in well-established
trailing areas of complete demyelination packed with
lipid macrophages, and, in some lesions, degenerating
oligodendrocytes, showed large numbers of T and B
cells, as well as immunoglobulin G (IgG)-positive plas-
ma cells. Lesions in two exceptionally early cases con-
tained a paucity of T and B cells, and no IgG-positive
plasma cells. The authors’ concluding interpretation
stressed that “early loss of oligodendrocytes is a promi-
nent feature in tissue bordering rapidly expanding MS
lesions. Macrophage activity is largely an innate scav-
enging response to the presence of degenerate and
dead myelin. The ﬁndings suggest that plaque formation
has some basis other than destructive cell-mediated im-
munity directed against myelin or oligodendrocyte anti-
gen” (77). 
Concluding remarks
It is obvious that, more than 150 years after Charcot’s ini-
tial description of MS, we still know far less than is nec-
essary to offer patients and their families durable symp-
tom relief, much less a cure for MS. All interested parties
continue to be confronted with more questions than an-
swers regarding the pathogenetic basis of MS, mainte-
nance of the disease, subtypes of disease expression,
and most effective and predictable therapeutic strategies. 
Historically, various aspects of vascular dysfunction
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Figure 9 - Scatter plot of the sum of dominant and subdominant
venous ﬂow (F(dv+sdv)) vs the total arterial ﬂow for 200 MS pa-
tients from two sites (100 from each site collected at approxima-
tely the C6 neck level). Note that F(dv+sdv) is shown in percen-
tage of F(ta). Each population was divided into non-stenotic
(NST) and stenotic (ST) groups based on cross-sectional area
analysis of the internal jugular veins on axial 2D time-of-ﬂight
MRV. ST patients show at least one stenosis in either internal ju-
gular vein and NST patients have no stenosis in either internal
jugular vein. It is seen that for MS patients from both sites, al-
most all of the patients that have an F(dv+sdv)/F(ta) ratio of less
than 50% are stenotic patients with only one NST patient mee-
ting this criterion. Also, 18 normal controls were assessed with
the same criterion. No normal control falls below a ratio of 50%. 
have been described in MS (78). Epidemiological stud-
ies suggest that patients with MS have a higher risk of
ischemic stroke than individuals who do not have MS
and multiple diagnostic modalities have demonstrated
that patients with MS exhibit global cerebral hypoperfu-
sion. CCSVI is a new hypothesis that has captured the
front page interest of patients worldwide and although
large, multi-institution trials (79) suggest it has an asso-
ciation with MS, the evidence to conﬁdently support its
fundamental role in the pathogenesis and progression of
this disease is currently lacking. 
It is readily appreciated that MS is a complex pathologi-
cal process, not unlike certain cancers, with its etiology
inﬂuenced by a variety of factors (genetic, infectious, en-
vironmental, dietary, inﬂammatory, etc.). The precise in-
terplay and requisite role(s) of contributing factors that
lead to the pathogenesis of MS is unknown. It is possi-
ble that the mosaic combination of individual etiological
elements responsible for disease expression is different
and even unique among those affected. It is currently
unknown whether CCSVI represents one of the factors
or risk factors that promotes or enables – along with oth-
ers – the development of MS (35).
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APPENDIX
A General Magnetic Resonance Imaging (MRI) Protocol for the Study of Chronic Cerebrospinal Venous
Insufﬁciency (CCSVI) in Multiple Sclerosis (MS) Patients
The CCSVI protocol uses a conventional neuro-MRI protocol for MS with additional specialized sequences to study the vasculature
in the brain, neck and spine as well as the iron content in the brain. On the vascular side, both anatomical and ﬂow information is col-
lected. MRI is also operator-independent for the most part and the same protocols can be run on most manufacturers’ systems. Po-
tential biomarkers for CCSVI and MS can be identiﬁed from the data. MRI can also longitudinally track the progress of the disease
over time via lesion counts and type, physiological changes like blood ﬂow and cerebrospinal ﬂuid (CSF) dynamics, and provide a
baseline for future scans. 
The following CCSVI imaging protocol is meant to complement conventional neurological examinations. The scans proposed for the
CCSVI research protocol include: time-resolved contrast enhanced (CE) 3D MR angiography and venography (MRAV), 2D time-of-
ﬂight MR venography (TOF MRV), 3D volumetric interpolated breath-hold examination (VIBE), phase-contrast (PC) ﬂow data at dif-
ferent levels in the neck and thoracic cavity, T2 weighted imaging (T2WI), T2 ﬂuid attenuated inversion recovery (FLAIR), suscepti-
bility weighted imaging (SWI), and pre- and post-contrast T1 weighted imaging (T1WI) or magnetization prepared rapid gradient echo
(MPRAGE) imaging. Perfusion scanning can also be added into this protocol for a small increment in time (roughly 3 minutes extra).
2D TOF MRV scans are used to detect blood ﬂow in arteries and veins. Using a saturation band, any ﬂow toward the head (arterial
ﬂow) will be saturated, and the ﬂow toward the heart (venous ﬂow) will be highlighted in a velocity-dependent manner. From this se-
quence, veins are well visualized and it can be determined if they are patent, occluded, or stenosed. Since the data are collected with
high resolution, vessel cross-section can also be calculated to evaluate the degree of stenosis.
3D CE MRAV can also be used to evaluate vascular abnormalities. The scan uses a T1 reducing contrast agent which passes through
all vessels and leads to increased signal for vessels in T1 weighted scans. From the data, 3D anatomical assessments can be done
to evaluate vessel patency. Atresias, aplasias, truncular malformations, valve issues, and stenoses can be detected. 
3D short TR, short TE VIBE pre- and post-contrast can be used to evaluate structural patency of vessels as well as inhomogeneous
enhancement of the tissue. It is an alternative approach to the 3D dynamic CE approach just discussed and takes much longer (al-
though it is still relatively fast).
PC images are used to assess ﬂow dynamics in the head and neck veins and arteries, the azygos vein, and CSF at the C2/C3 cer-
vical level. This information is critical because it can both corroborate and complement the information seen in the 2D TOF MRV and
3D CE MRAV. It is not uncommon to visualize the major veins only later to ﬁnd that many of the veins have compromised blood ﬂow.
Often, there will be no clear anatomical evidence of venous stenosis, but the quantitative ﬂow information will reveal abnormalities. 
SWI is useful because the image contrast is based on the intrinsic susceptibilities of tissues. For example, veins are rich in deoxyhe-
moglobin which is paramagnetic and provides clear visibility of venous structures. Quantiﬁcation of iron in the gray matter as well as
lesions can be accomplished using T2*, phase or susceptibility mapping from the phase images. SWI is also useful in assessing blood
products such as microbleeds and hemorrhages, possibly due to traumatic brain injury, vascular dementia, or MS. An interleaved
SWI/MRA sequence can reveal arteries and veins on the order of a few hundred microns by means of a dual-echo sequence. 
For more conventional imaging, T2WI is used to show tissue with long T2 components such as edema, CSF, tumors, and MS lesions.
3D T2 FLAIR is used because the images have suppressed CSF signal. FLAIR shows periventricular lesions well without the inter-
ference from CSF. Lesion quantity and volume can also be assessed with FLAIR. Eventually it may be possible to compare lesion
volume with blood ﬂow or patient’s physiological changes over time. T1WI is used at two parts of the scanning protocol to image the
head: initially before contrast agent injection, and after contrast agent injection. Lesions that enhance post-contrast are considered
acute. Standardized guidelines for brain and spinal cord scanning in MS are widely available and differ according to whether used for
clinical or research purposes (80,81).
PWI is used to evaluate the hemodynamics of the brain. From this data it is possible to assess mean transit time (MTT) which is the
time it takes for contrast agent to pass through the microvasculature, the cerebral blood volume (CBV) and the cerebral blood ﬂow
(CBF). 
In summary, the use of quantitative MR imaging methods such as those described above may provide objective evidence for ﬂow ab-
normalities in MS patients.
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